[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
September 2005

Error in Reference List in: Pulsed High-Dose Corticosteroids Combined With Low-Dose Methotrexate in Severe Localized Scleroderma

Arch Dermatol. 2005;141(9):1091. doi:10.1001/archderm.141.9.1091

Error in Reference List. In the Study by Kreuter et al titled “Pulsed High-Dose Corticosteroids Combined With Low-Dose Methotrexate in Severe Localized Scleroderma,” published in the July issue of the ARCHIVES (2005;141:847-852), the following references were omitted from the reference list. This correction was made previously to online versions of this article.

  • 23. Sato S, Fujimoto M, Kikuchi K, Ihn H, Tamaki K, Takehara K. Soluble CD4 and CD8 in serum from patients with localized scleroderma. Arch Dermatol Res. 1996;288:358-362.

  • 24. Falanga V, Medsger TA Jr, Reichlin M, Rodnan GP. Linear scleroderma: clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med. 1986;104:849-857.

  • 25.  Heickendorff L, Zachariae H, Bjerring P, Halkier-Sorensen L, Sondergaard K. The use of serologic markers for collagen synthesis and degradation in systemic sclerosis. J Am Acad Dermatol. 1995;32:584-588.

  • 26.  Hulshof MM, Bouwes Bavinck JN, Bergman W, et al. Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol. 2000;43:1017-1023.

×